Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.

Item
http://www.wikidata.org/entity/Q44131214
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancerChemotherapy of ovarian cancer in elderly patientsCA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trialFinal overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytesHypersensitivity reactions to carboplatin and cisplatin in non-small cell lung cancer.Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactionsRecurrent ovarian cancer: when and how to treat.IgE and chemotherapy.Increasing the chances for platinum-sensitive ovarian cancer patients.Platinum hypersensitivity and desensitization.Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.Carboplatin hypersensitivity: evaluation and successful desensitization protocol.Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer.When nonplatinum is the answer: the role of trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer.Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.
P2860

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.

Item
http://www.wikidata.org/entity/Q44131214
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@en
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@nl
type
label
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@en
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@nl
prefLabel
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@en
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Decreased hypersensitivity rea ...... elapsing ovarian cancer trial.
@en
P2093
P304
P31
P356
10.1016/J.YGYNO.2011.04.019
P407
P433
P478
P50
P577
P698
P921